Dermatology Biosimilar Market

Future Market Insights

Dermatology Biosimilar Market

Key Insight

The dermatology biosimilar market is projected to grow from USD 24.7 billion in 2025 to USD 42.6 billion by 2035, at a CAGR of 5.6%. Adalimumab Biosimilars will dominate with a 48.3% market share, while plaque psoriasis will lead the indication segment with a 55.7% share.

October 30, 2025

Anurag Sharma

250 Pages

Cite this Report

Dermatology Biosimilar Market

https://www.futuremarketinsights.com/reports/dermatology-biosimilar-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Alvotech
Amgen
Biocon Ltd
Celltrion Inc
The Vanguard Group
Samsung Bioepis Co. Ltd
Sandoz
Viatris Inc

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Dermatology Biosimilar Market

Key Players

Similar Industry Reports